We recently report that the expression of polycomb chromobox 4 (Cbx4) is significantly correlated with the overall survival of a great cohort of hepatocellular carcinoma (HCC) patients and it enhances hypoxia-induced vascular endothelial growth factor (VEGF) expression and angiogenesis in HCC cells through enhancing sumoylation of hypoxia inducible factor-1alpha (HIF-1α). Here we continue to investigate the potential effects of Cbx4 on the migration and metastasis of the metastatic HCC cell line MHCC97L. Our results show that Cbx4 overexpression in the cell line increases the in vitro vessel formation of vascular endothelial cells in its SUMO interaction motifs-dependent manner, and promotes the in vitro migration of the cancer cell, which can be effectively abrogated by anti-VEGF antibody. Although Cbx4 expression does not impact the in vitro growth of MHCC97L cells, it still promotes the progression and metastasis of orthotopically transplanted tumors in nude mice. These results further support the role of Cbx4 as a SUMO E3 ligase in the progression and metastasis of HCC. polycomb chromobox 4, hepatocellular carcinoma, vascular endothelial growth factor, metastasis
Polycomb group proteins (PcG), a set of transcriptional repressors which impose the histone H3 lysine 27 tri-methylation for repression of gene expression [1, 2] , assemble into at least two major classes of multimeric protein polycomb repressive complexes (PRC) in mammal, that is, PRC1 and PRC2. They are essential for embryonic development and stem cell renewal and contribute widely to a series of biological processes such as cell cycle, DNA repair, cell differentiation, senescence and death [1,35] . Accordingly, the increasing lines of evidence demonstrate that dys-regulations of genes encoding PcG proteins, such as Bmi1, Cbx7 and Ezh2 are associated with tumorigenesis of many kinds of cancers [68] .
Like other members of the Cbx family, polycomb chromobox (Cbx) protein 4 (Cbx4, also designated as polycomb 2, Pc2) can bind to methylated histones as an important component for PRC1 [9] . However, Cbx4 but not other members of Cbx family has also been reported to act as the small ubiquitin-related modifier (SUMO) E3 ligase, which can enhance the sumoylation of transcriptional co-repressor C terminal binding protein (CtBP) [10] , Smad-interacting protein 1 (SIP1) [11] , DNA methyltransferase 3a (Dnmt3a) [12] , multifunctional Ca 2+ -binding protein centrin-2 [13] and homeodomain-interacting protein kinase 2 (HIPK2) [14] . Structural analyses reveal that the N-terminal chromodomain and two SUMO interaction motifs (SIM1 and SIM2) appear to be required for its repressor and SUMO E3 ligase activity, respectively [1518] .
More recently, we reported that Cbx4 expression is significantly correlated with the overall survival of a great cohort of hepatocellular carcinoma (HCC) patients and of subcutaneously and orthotopically transplanted HCC mice [17] . Further, Cbx4 enhances hypoxia-induced vascular endothelial growth factor (VEGF) expression and angiogenesis in HCC cell lines such as SMMC-7721, HepG-2, BEL-7402 and MHCC97L [17] . Mechanically, Cbx4 enhances sumoylations of hypoxia inducible factor-1alpha (HIF-1α) protein, thus increasing the transcriptional activity of HIF-1 in its SUMO E3 ligase activity-dependent mechanisms [17, 18] . Here we continue to investigate the potential effects of Cbx4 on the migration and metastasis of MHCC97L, a metastatic HCC cell line [19] . puromycin was added to select stable cell lines, as we described previously [17] .
Plasmid construction
Cbx4-expressing pCMV plasmids with amino-terminal Flag tag were generously provided by Dr. Weng JieMin at East China Normal University (Shanghai, China). Flag-tagged Cbx4 mutants were constructed by using QuikChange TM Lightning Site-Directed Mutagenesis Kit (Stratagene, USA). Flag-Cbx4 and its mutants were cloned into pBABE puro vector (Cell Biolabs, Inc., USA) for stable transfection as described previously [17] .
In vitro tube formation
According to the manufacturer's instructions, the Matrigel was placed in a refrigerator at 4°C overnight to thaw. Once it had thawed, 24-well plates were coated with 100 L/well of Matrigel (BD Biosciences, USA) and immediately placed in an incubator at 37°C for 1 h. HUVEC (210 4 ) in 1 mL of conditional DMEM medium, which had been incubated with 1.510 5 MHCC97L cells for 48 h, were seeded onto the solidified gel. After incubating in an atmosphere of 5% CO 2 and 95% air at 37°C for 16 h to allow the formation of a capillary-like structure, the endothelial tubes were counted under photomicroscope at 200× magnification over five fields in each slide.
Immunohistological chemistry staining
Sections were stained with anti-Cbx4 (dilution 1:25, SC-19299, USA) and anti-VEGF polyclonal antibody (dilution 1:500, SC-152, USA) to analyze their protein levels. All responses were followed by staining with the corresponding HRP-conjugated secondary antibody (KIT-9719 and KIT-9707, Maixin Biotechnology, China). Images were captured by Nikon Ti-S microscope equipped with a digital camera system (Nikon).
Cell counting Kit-8 (CCK8) assay
MHCC97L cells were plated in 96-well plates at the density of 1000 cells per well with 100 μL of complete culture medium. After adhesion for 24 h, the cells were cultured for additional 24, 48, 72, 96 and 120 h. The wells only with the culture medium were used as blank controls. At each time point, the supernatant was removed and 100 μL of DMEM medium containing 10 μL of CCK8 (Dojindo, Japan) was added to each well for additional 3 h at 37°C. The absorbance was recorded at 450 nm. All experiments were independently repeated at least three times.
Flow cytometry analysis
To analyze cellular DNA content by flow cytometry, 110 6 cells were collected, rinsed and fixed overnight with 75% cold ethanol at 20°C. Cells were then treated with 100 μg mL 1 RNase A in Tris-HCl buffer (pH 7.4) and stained with 25 μg mL 1 propidium iodide (PI, Sigma-Aldrich, USA).
Samples were then subjected to the analysis by flow cytometry (FACSCalibur, BD Biosciences, USA) using CellQuest Pro software (BD Biosciences). Ten thousand cells were acquired and analyzed for the DNA content.
Migration assay
The MHCC97L cells (1.5×10 5 cells per 100 μL) in serum and insulin-free DMEM with or without anti-VEGF antibody were seeded on 8-μm pore transwell inserts (Corning Costar No. 3422; Corning, USA). After 24 h, cells on the upper side of the inserts were removed with a cotton swab.
For evaluation of cells that migrated onto the lower surface, inserts were fixed in 4% paraformaldehyde for 15 min and dyed in 0.1% crystal violet for 45 min. The transwell membranes were then removed, placed on a glass slide with the side containing cells facing up, overlaid with a cover slip (VWR ® Micro Cover Glasses, Round, No. 1). Migrated cells were counted in five non-overlapping locations, which covered approximately 70% of the insert membrane growth area, using a Nikon Ti-S microscope equipped with a digital camera system (Nikon). The experiment was repeated at least three times.
Western blot
Protein extracts were quantified and separated by 10% SDS-polyacrylamide gel, and transferred to the Immobilon™PVDF Transfer Membranes (Millipore Corporation, USA). After blocking with 5% nonfat milk in PBS, membranes were immunoblotted with anti-Flag antibody (F1804, Sigma, Germany) together with anti--actin antibody (Merck, Germany) as the internal control. Then horseradish peroxidase (HRP)-linked secondary antibody (Cell Signaling, USA) was incubated for 1 h at room temperature. The signals were detected by ImmobilonTM Western Chemiluminscent HRP Substrate kit (Millipore Corporation).
Animal experiments
GFP-Luciferase-labeled MHCC97L cells (3×10 6 ) suspended in 40 µL of DMEM/Matrigel (1:1) were orthotopically inoculated into the left hepatic lobe of six-week-old male BALB/c nude mice under anesthesia, which were obtained from Shanghai SLAC Laboratory Animal Co. (China). Anesthetized mice were retroorbitally injected with 75 mg kg 1 D-Luciferin (360202, CellCyto), and the photon fluxes (photons per second) emitted from tumor cells was monitored by bioluminescent images (BLI). Bioluminescence images were acquired with the IVIS Imaging System (Xenogen, USA). Analysis was performed with Living Image software (Xenogen) by measuring photon flux of the upper abdominal and thoracic region. Data were normalized to the signal obtained immediately after injection (day 0). At day 35, mice were sacrificed. All livers and lungs were dissected, fixed with phosphate-buffered neutral formalin, paraffin-embedded and cut in slices. All animals were handled in strict accordance to the "Guide for the Care and Use of Laboratory Animals" and the "Principles for the Utilization and Care of Vertebrate Animals", and all animal work was approved by the Institutional Animal Care and Use Committee at the Shanghai Jiao Tong University School of Medicine.
Statistical analysis
The P values for comparison between line-linked groups were obtained by student's t-test. All statistical tests were two-sided, and P<0.05 were considered to be statistically significant.
Results

Cbx4 increases in vitro vessel formation in its SIMs-dependent manner
As we previously mentioned [17] , Cbx4 enhances hypoxia-incubated HCC cell lines including MHCC97L cells to produce VEGF, a master stimulator of angiogenesis and vascular permeability in cancer tissues [20] . Thus, we detected whether Cbx4 affects the in vitro vessel formation in the co-culture system of HUVEC and MHCC97L cells with or without ectopic stable expression of Flag-tagged wildtype Cbx4 (Cbx4-WT), Cbx4-CDM or Cbx4-SIM1/2 ( Figure 1A) , in which Cbx4-CDM mutant carries F11A/ W35L double-mutation in its chromodomain of Cbx4 and loses its polycomb function but still presents SUMO E3 ligase activity, while Cbx4-SIM1/2 mutant is absent of their two SIMs and lose SUMO E3 ligase activity [17] . In line with those seen in HCC cell line SMMC-7721 [17] , overexpression of Cbx4-WT and Cbx4-CDM in MHCC97L cells also increased the vessel formation of HUVEC. However, such an effect could not be seen in the Cbx4-SIM1/2 mutant-expressing cells ( Figure 1B and C).
Cbx4 promotes the migration of MHCC97L cells by increasing VEGF
It has been known that VEGF-mediated signaling in cancer is not limited to angiogenesis, and also contributes to other key aspects of tumorigenesis such as tumor metastasis [20, 21] . Therefore, we tested the potential effects of Cbx4 and its mutants on the migration of MHCC97L cells by transwell experiments. Our results showed that hypoxia but not normoxia increased migration of MHCC97L cells, which was significantly enhanced by overexpressions of Cbx4-WT and Cbx4-CDM but not Cbx4-SIM1/2 ( Figure  2 ), suggesting that Cbx4 promotes the hypoxia-induced migration of cancer cells, which is also dependent on its SIMs domains.
To determine whether the increased VEGF under hypoxia contributes to the enhanced migration of MHCC97L cell with stable ectopic Cbx4-WT and Cbx4-CDM expression, we treated these cells together with anti-VEGF antibody to neutralize VEGF under hypoxia and normoxia, followed by the transwell experiments. The results showed that anti-VEGF antibody almost completely inhibited the hypoxia-stimulated migration of MHCC97L cells in spite of the expressions of Cbx4-WT, Cbx4-CDM or Cbx4-SIM1/2 ( Figure 2 ). All these results indicate that Cbx4-promoting migration of MHCC97L cells is mediated by the increased VEGF expression.
Cbx4 fails to regulate growth and cell cycle progression of MHCC97L cells
Previously, we reported that Cbx4 did not affect cell growth of HCC cells under normoxia [17] . Here we further showed that ectopic expressions of Cbx4 and its two mutants did not significantly interfere with the growth of MHCC97L cells under hypoxia ( Figure 3A) . Furthermore, we analyzed the cell cycle distribution in these MHCC97L with or without overexpression of Cbx4 and its mutants. The results also support that Cbx4 and its mutants did not regulate cell cycle progression of the HCC cell line under either normoxia ( Figure 3B ) or hypoxia ( Figure 3C ).
Cbx4 enhances the in vivo growth of MHCC97L cell-transplanted tumors
Although Cbx4 expression did not impact the in vitro growth of MHCC97L cells, we still directly injected GFP-luciferase-labeled MHCC97L cells expressing vehicle, Cbx4-WT, Cbx4-CDM and Cbx4-SIM1/2 into the livers of BALB/c nude mice, followed by monitoring luciferase photon fluxes each week. The results demonstrated that like those in SMMC-7721 cells [17] , fluorescence intensities of tumors with ectopic expressions of Cbx4-WT and Cbx4-CDM were greatly higher than those of vehicle and Cbx4-SIM1/2 ( Figure 4A ). The representative noninvasive BLI at the 5th week after orthotopical injection are shown (Figure 4B) . Then, we executed and dissected the nude mice in the 5th week post-transplantation. As depicted in Figure 4C , liver tumors with Cbx4-WT and Cbx4-CDM overexpressions were much bigger and more widely distributed in livers than those with vehicle and Cbx4-SIM1/2-express-ing cells. In line with the notion, nude mice transplanted with Cbx4-WT and Cbx4-CDM but not Cbx4-SIM1/2 had more numbers of tumor nodules in livers ( Figure 4D ). As consistent with our previous report in HCC cell line SMMC-7721 cells [17] , additionally, Cbx4 and Cbx4-CDM but not Cbx4-SIM1/2 expressions remarkably increased VEGF expression in the transplanted tumors, as estimated by immunohistochemical staining ( Figure 4E ). 
Cbx4 promotes the metastasis of MHCC97L cells in vivo
Based on our observation that Cbx4 and Cbx4-CDM expression remarkably increased the in vitro migration of MHCC97L cells under hypoxia (Figure 2) , we also observed the potential tumors in other tissues besides livers. The results showed that there was a higher frequency of pulmonary metastasis and the more tumor nodule numbers in lungs of the nude mice injected with MHCC97L cells stably expressed Cbx4-WT and Cbx4-CDM than vehicle and Cbx4-SIM1/2 ( Figure 5A) . A representative image for lung metastasis from nude mice with the transplantation of Cbx4-expressing MHCC97L cells is shown in Figure 5B .
All these results support that like SMMC7721 cells previously reported [17] , Cbx4 but not its SUMO E3 ligase activity-absent Cbx4-SIM1/2 could promote in vivo metastasis of MHCC97L cells.
Discussion
Hepatocellular carcinoma is one of the most common cancers worldwide, with an increasing incidence in Asian and also in Western countries as a result of increasing hepatitis B and hepatitis C virus infection [22] . More than 80% of patients with HCC have been associated with cirrhosis and impaired liver function, making treatment of HCC more Figure 3 Cbx4 has no effect on proliferation and cell cycle progression of MHCC97L cells. A, MHCC97L cells ectopically expressing Flag-tagged Cbx4-WT and its mutants were incubated under hypoxia for the indicated days. The growth rates were measured by CCK8 assay normalized to vehicle cells at 0 h. B and C, MHCC97L cells transfected with Flag-tagged Cbx4-WT and its mutants were incubated under normoxia or hypoxia for 48 h, followed by flow cytometric analysis for DNA distribution. The percentage of cells at each stage of cell cycle was quantified. All these experiments were repeated for at least three times with the same results. difficult than many other cancers. HCC is a hypervascular tumor characterized by neovascularization, which plays an important role in the growth and progression of HCC. Therefore, it is proposed that angiogenesis provides a target for novel prognostic and therapeutic approaches to HCC [23, 24] . Currently, available antiangiogenic cancer chemotherapy targeting the VEGF pathway by monoclonal anti-VEGF antibody bevacizumab or multi-targeted receptor tyrosine kinase inhibitors such as sorafenib has emerged [25, 26] . On the other hand, HIF-1 induces expression of angiogenic growth factors such as VEGF, stromal derived factor 1, angiopoietin 2, platelet-derived growth factor B and stem cell factor. Therefore, it is a key regulatory factor for angiogenesis in response to hypoxia and plays an important role in the pathogenesis of cancers including HCC, suggesting the possibility of HIF-1α as a novel therapeutic target in HCC [27] . More recently, we reported that Cbx4 governs HIF-1α to increase VEGF production and thus potentiate angiogenesis of HCC by its SUMO E3 ligase activity [17] . Because VEGF also contributes to other oncogenesis events besides angiogenesis [20, 21, 28 ], here we investigate the potential impacts of Cbx4 on migration and metastasis of HCC cell line MHCC97L. We demonstrate that the overexpression of Cbx4 but not its SUMO E3 ligase activity-absent mutant in MHCC97L increases in vitro hypoxia-stimulated vessel formation of HUVEC, which is consistent with our previous observation that Cbx4 enhances VEGF production in the HCC cell line SMMC-7721 [17] . More interestingly, we also find that Cbx4 promotes the migration on transwell of MHCC97L cells under hypoxia but not normoxia, for which its SIMs are necessary. Especially, anti-VEGF antibody almost completely inhibits migration-enhancing effect of Cbx4, indicating that this event is mediated by the increased VEGF expression.
It was reported that targeted disruption of Cbx4 causes severe hypoplasia of the fetal thymus as a result of reduced thymocyte proliferation [29] . Cbx4 was also shown to maintain human epidermal stem cells as slow-cycling and undifferentiated, and inhibit stem cell activation and differentiation through its SUMO ligase activity [30] . More recently, it was also reported that Cbx4 knockdown led to the decreased proliferation and impaired cell cycle progression in HCC cell lines [31] . However, our results show that Cbx4 fails to regulate growth and cell cycle progression of MHCC97L cells under either hypoxia or normoxia. In spite of this, tumors from subcutaneously transplanted SMMC7721 and MHCC97L cell lines with the overexpression of Cbx4-WT and CDM mutant but not SIM1/2 mutant grew more rapidly compared with vehicle controls [17] . Here we further reveal that tumors from orthotopically transplanted MHCC97L cell lines with the overexpression of Cbx4 but not SIM1/2 mutant also grew more rapidly, as seen in orthotopically transplanted SMMC-7721 cells [17] . Of great importance, these orthotopically transplanted MHCC97L cells with Cbx4 overexpression present significantly higher ability of pulmonary metastasis.
Taken together, our results further support that Cbx4 plays an extremely important role in the process of progression and metastasis of HCC through its SUMO E3 ligase activity. Therefore, to explore the agents to target SUMO E3 ligase activity of Cbx4 might be of great significance for the treatment of HCC patients.
